Technology area
Medical device
1,020 funded awards, $699.0M total, FY2023-FY2025.
Where the money sat, by Institute / Center
IC funding decisions are set by portfolio priorities, NOFO scope, and program-officer judgment. These are funded records, not predictions of future funding.
| IC | Name | Records | Median award |
|---|---|---|---|
| HL (NHLBI) | National Heart Lung and Blood Institute | 229 | $833,493 |
| DK (NIDDK) | National Institute of Diabetes and Digestive and Kidney Diseases | 125 | $540,238 |
| HD (NICHD) | Eunice Kennedy Shriver National Institute of Child Health and Human Development | 89 | $761,233 |
| DA (NIDA) | National Institute on Drug Abuse | 79 | $400,000 |
| AI (NIAID) | National Institute of Allergy and Infectious Diseases | 78 | $913,040 |
| NS (NINDS) | National Institute of Neurological Disorders and Stroke | 75 | $515,503 |
| AG (NIA) | National Institute on Aging | 72 | $505,791 |
| CA (NCI) | National Cancer Institute | 68 | $747,160 |
| AR (NIAMS) | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 35 | $384,999 |
| MH (NIMH) | National Institute of Mental Health | 33 | $594,170 |
| EY (NEI) | National Eye Institute | 21 | $795,000 |
| EB (NIBIB) | National Institute of Biomedical Imaging and Bioengineering | 21 | $796,446 |
| GM (NIGMS) | National Institute of General Medical Sciences | 20 | $718,397 |
| DC (NIDCD) | National Institute on Deafness and Other Communication Disorders | 18 | $333,732 |
| MD (NIMHD) | National Institute on Minority Health and Health Disparities | 16 | $323,792 |
| TR (NCATS) | National Center for Advancing Translational Sciences | 11 | $350,000 |
| NR (NINR) | National Institute of Nursing Research | 9 | $716,570 |
| DE (NIDCR) | National Institute of Dental and Craniofacial Research | 7 | $976,000 |
| ES (NIEHS) | National Institute of Environmental Health Sciences | 6 | $294,832 |
| AT (NCCIH) | National Center for Complementary and Integrative Health | 3 | $294,312 |
| LM (NLM) | National Library of Medicine | 2 | $362,371 |
| HG (NHGRI) | National Human Genome Research Institute | 1 | $404,117 |
| AA (NIAAA) | National Institute on Alcohol Abuse and Alcoholism | 1 | $385,000 |
| OD | NIH Office of the Director | 1 | $324,240 |
FOA / NOFO routes
Opportunity number prefixes: PA = Parent Announcement (broad, omnibus, multiple ICs), PAR = Parent with Special Review, PAS = Parent with set-aside funds, RFA = Request for Applications (targeted, single-IC, fixed budget). Status unknown means the pipeline has not verified whether the FOA is currently posting awards; the SBIR omnibus has been in reauthorization gap during this window. See the glossary for full definitions.
| Opportunity | Status | Records |
|---|---|---|
| PA-22-176 | unknown | 182 |
| PA-23-230 | unknown | 134 |
| PA-21-259 | unknown | 79 |
| PA-24-245 | unknown | 65 |
| PA-23-231 | unknown | 47 |
| PA-22-177 | unknown | 43 |
| PA-22-178 | unknown | 38 |
| PA-23-232 | unknown | 37 |
| PA-21-260 | unknown | 31 |
| PA-20-260 | unknown | 30 |
| RFA-DA-23-021 | unknown | 25 |
| PA-21-262 | unknown | 22 |
| RFA-HL-23-009 | unknown | 18 |
| PA-20-272 | unknown | 18 |
| PA-24-247 | unknown | 17 |
| PA-21-345 | unknown | 16 |
| PAR-22-073 | unknown | 16 |
| PA-20-262 | unknown | 15 |
| PAS-22-196 | unknown | 15 |
| PA-24-246 | unknown | 13 |
| RFA-DA-19-019 | unknown | 10 |
| RFA-NS-23-006 | unknown | 7 |
| PA-23-233 | unknown | 6 |
| RFA-NS-20-009 | unknown | 6 |
| PAR-24-131 | expired | 6 |
| RFA-NS-23-007 | unknown | 5 |
| PA-19-272 | unknown | 5 |
| RFA-NS-20-011 | unknown | 5 |
| RFA-HL-23-008 | unknown | 4 |
| RFA-DA-23-018 | unknown | 4 |
| RFA-DA-19-020 | unknown | 4 |
| PAR-21-266 | unknown | 4 |
| PAR-23-032 | unknown | 4 |
| PA-20-261 | unknown | 4 |
| RFA-MD-24-006 | unknown | 3 |
| RFA-MD-22-004 | unknown | 3 |
| RFA-CA-22-017 | unknown | 3 |
| PAR-23-311 | expired | 3 |
| PA-21-261 | unknown | 3 |
| PA-25-212 | unknown | 3 |
| RFA-DA-23-020 | unknown | 3 |
| RFA-MD-23-003 | unknown | 3 |
| PA-22-179 | unknown | 3 |
| PA-18-574 | unknown | 3 |
| RFA-HL-19-017 | unknown | 3 |
| PAR-21-265 | unknown | 2 |
| PAS-22-197 | unknown | 2 |
| RFA-CA-23-034 | unknown | 2 |
| RFA-AG-24-042 | unknown | 2 |
| PA-24-248 | unknown | 2 |
| PA-24-254 | unknown | 2 |
| RFA-CA-21-001 | unknown | 2 |
| RFA-AG-22-014 | unknown | 2 |
| PAR-18-618 | unknown | 2 |
| PA-19-273 | unknown | 2 |
| PA-20-265 | unknown | 2 |
| PA-18-579 | unknown | 2 |
| PAS-19-316 | unknown | 2 |
| RFA-AG-21-025 | unknown | 2 |
| RFA-CA-24-023 | unknown | 1 |
| RFA-DA-25-050 | unknown | 1 |
| PA-24-253 | unknown | 1 |
| PAR-24-222 | expired | 1 |
| PAR-20-129 | unknown | 1 |
| RFA-ES-23-005 | unknown | 1 |
| RFA-MD-23-002 | unknown | 1 |
| RFA-DA-24-018 | unknown | 1 |
| PAR-21-225 | unknown | 1 |
| PA-23-189 | unknown | 1 |
| RFA-NS-20-010 | unknown | 1 |
| PA-18-591 | unknown | 1 |
| PAR-18-108 | unknown | 1 |
| PA-18-819 | unknown | 1 |
| RFA-MD-22-003 | unknown | 1 |
| PAS-19-317 | unknown | 1 |
| PA-19-270 | unknown | 1 |
| RFA-HL-19-018 | unknown | 1 |
| PA-18-870 | unknown | 1 |
| RFA-CA-20-033 | unknown | 1 |
| PAR-19-333 | unknown | 1 |
| PA-18-566 | unknown | 1 |
| RFA-DK-21-011 | unknown | 1 |
| RFA-AG-23-029 | unknown | 1 |
Comparable funded projects
| ApplID | FY | IC | Title | Organization | Amount |
|---|---|---|---|---|---|
| 10845690 | 2025 | HL | Development of the Inspired Therapeutics NeoMate Mechanical Circulatory Support System for Neonates and Infants | INSPIRED THERAPEUTICS, LLC | $2,632,311 |
| 10886144 | 2025 | NR | Addressing adoption barriers to patient transportation services | TRANSCENDENT INTERNATIONAL, LLC | $734,677 |
| 10921587 | 2025 | DE | AI-linked cytomics-on-a-chip to enable near-real time identification and management of oral lichenoid lesions in primary care | ORALIVA, INC. | $1,178,476 |
| 10932426 | 2025 | NS | Kv2.1-Targeted First in Class Neuroprotective Therapeutic for Acute Ischemic Stroke | CELDARA MEDICAL, LLC | $421,106 |
| 10934363 | 2025 | AR | 3D Printed Silicon Nitride Porous PEEK Composite Spinal Cages for Anti-Infection | SINTX TECHNOLOGIES, INC. | $745,427 |
| 10939434 | 2025 | MD | The Language Equity and Accessibility Performance (LEAP) Initiative: Addressing disparities through a paradigm shift in language services operations | TRANSCENDENT INTERNATIONAL, LLC | $981,286 |
| 10939438 | 2025 | MD | Addressing Gaps in Language Access Services through a Patient-Centered Decision-Support Tool | TRANSCENDENT INTERNATIONAL, LLC | $910,324 |
| 10953826 | 2025 | HL | A non-invasive, automated platform for hemodynamic assessment of patients at risk of heart failure or pulmonary hypertension | SENSYDIA CORPORATION | $1,607,970 |
Limitations
- RePORTER includes funded projects only, not unfunded applications.
- Panel sidebar reflects panels that have appeared on funded records, not future assignment.
- FOA-route status reflects verification at the timestamp shown.
- Tag 'medical_device' is a Cada controlled-vocabulary tag; see methodology for definitions.
Pattern read
Medical device is a large tag (1,020 records) and the IC spread is what you'd expect: NHLBI at 229 (cardiac, pulmonary, vascular devices), NIDDK at 125 (diabetes, GI, urology devices), NICHD at 89 (pediatric and obstetric devices), then NIDCD and NINDS. Median award is $639K, on the higher side, which fits the engineering and verification costs typical of device development. R44 share (591) is dominant. STTR (R41 at 111) reflects ongoing academic-engineering origin patterns. Concentration is the lowest of the larger tags at 2.6%; the medical-device landscape in NIH SBIR is genuinely diffuse.
Fit indicators
Watchouts